↓ Skip to main content

Risk of infections in bronchiectasis during disease-modifying treatment and biologics for rheumatic diseases

Overview of attention for article published in BMC Infectious Diseases, November 2011
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
2 X users

Citations

dimensions_citation
44 Dimensions

Readers on

mendeley
35 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Risk of infections in bronchiectasis during disease-modifying treatment and biologics for rheumatic diseases
Published in
BMC Infectious Diseases, November 2011
DOI 10.1186/1471-2334-11-304
Pubmed ID
Authors

Guillaume Geri, Sabrina Dadoun, Tach Bui, Nuria Del Castillo Pinol, Simon Paternotte, Maxime Dougados, Laure Gossec

Abstract

Bronchiectasis is frequently associated (up to 30%) with chronic inflammatory rheumatic diseases and leads to lower respiratory tract infections. Data are lacking on the risk of lower respiratory tract infections in patients treated with biologic agents.

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 35 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 3%
Japan 1 3%
Unknown 33 94%

Demographic breakdown

Readers by professional status Count As %
Lecturer 4 11%
Researcher 4 11%
Student > Master 4 11%
Other 3 9%
Student > Postgraduate 3 9%
Other 11 31%
Unknown 6 17%
Readers by discipline Count As %
Medicine and Dentistry 18 51%
Biochemistry, Genetics and Molecular Biology 2 6%
Immunology and Microbiology 2 6%
Pharmacology, Toxicology and Pharmaceutical Science 1 3%
Nursing and Health Professions 1 3%
Other 4 11%
Unknown 7 20%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 02 May 2019.
All research outputs
#13,357,126
of 22,656,971 outputs
Outputs from BMC Infectious Diseases
#3,317
of 7,630 outputs
Outputs of similar age
#86,398
of 141,797 outputs
Outputs of similar age from BMC Infectious Diseases
#47
of 101 outputs
Altmetric has tracked 22,656,971 research outputs across all sources so far. This one is in the 39th percentile – i.e., 39% of other outputs scored the same or lower than it.
So far Altmetric has tracked 7,630 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.6. This one has gotten more attention than average, scoring higher than 54% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 141,797 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 37th percentile – i.e., 37% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 101 others from the same source and published within six weeks on either side of this one. This one is in the 47th percentile – i.e., 47% of its contemporaries scored the same or lower than it.